TrialThe Korean journal of internal medicine2018

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.

Young Mo Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.